nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Estropipate—osteoporosis	0.4	0.707	CbGbCtD
Gatifloxacin—ALB—Estradiol—osteoporosis	0.166	0.293	CbGbCtD
Gatifloxacin—Shock—Pamidronate—osteoporosis	0.000357	0.000837	CcSEcCtD
Gatifloxacin—Loss of consciousness—Zoledronate—osteoporosis	0.000357	0.000837	CcSEcCtD
Gatifloxacin—Pharyngitis—Estradiol—osteoporosis	0.000357	0.000836	CcSEcCtD
Gatifloxacin—Hypersensitivity—Estropipate—osteoporosis	0.000356	0.000834	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Pamidronate—osteoporosis	0.000355	0.000833	CcSEcCtD
Gatifloxacin—Vomiting—Etidronic acid—osteoporosis	0.000355	0.000832	CcSEcCtD
Gatifloxacin—Oedema peripheral—Estradiol—osteoporosis	0.000354	0.00083	CcSEcCtD
Gatifloxacin—Tachycardia—Pamidronate—osteoporosis	0.000354	0.00083	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—WDR1—osteoporosis	0.000353	0.0441	CbGpPWpGaD
Gatifloxacin—Rash—Etidronic acid—osteoporosis	0.000352	0.000825	CcSEcCtD
Gatifloxacin—Convulsion—Zoledronate—osteoporosis	0.000352	0.000825	CcSEcCtD
Gatifloxacin—Dermatitis—Etidronic acid—osteoporosis	0.000351	0.000824	CcSEcCtD
Gatifloxacin—Vertigo—Conjugated Estrogens—osteoporosis	0.000351	0.000824	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Pamidronate—osteoporosis	0.000351	0.000822	CcSEcCtD
Gatifloxacin—Syncope—Conjugated Estrogens—osteoporosis	0.00035	0.000822	CcSEcCtD
Gatifloxacin—Hypertension—Zoledronate—osteoporosis	0.00035	0.000822	CcSEcCtD
Gatifloxacin—Hypersensitivity—Alendronate—osteoporosis	0.00035	0.000822	CcSEcCtD
Gatifloxacin—Headache—Etidronic acid—osteoporosis	0.000349	0.00082	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000347	0.000815	CcSEcCtD
Gatifloxacin—Asthenia—Estropipate—osteoporosis	0.000346	0.000812	CcSEcCtD
Gatifloxacin—Visual impairment—Estradiol—osteoporosis	0.000346	0.000812	CcSEcCtD
Gatifloxacin—Anorexia—Pamidronate—osteoporosis	0.000346	0.000811	CcSEcCtD
Gatifloxacin—Myalgia—Zoledronate—osteoporosis	0.000345	0.00081	CcSEcCtD
Gatifloxacin—Chest pain—Zoledronate—osteoporosis	0.000345	0.00081	CcSEcCtD
Gatifloxacin—Arthralgia—Zoledronate—osteoporosis	0.000345	0.00081	CcSEcCtD
Gatifloxacin—Palpitations—Conjugated Estrogens—osteoporosis	0.000345	0.00081	CcSEcCtD
Gatifloxacin—Insomnia—Risedronate—osteoporosis	0.000345	0.000809	CcSEcCtD
Gatifloxacin—Anxiety—Zoledronate—osteoporosis	0.000344	0.000808	CcSEcCtD
Gatifloxacin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000343	0.000806	CcSEcCtD
Gatifloxacin—Paraesthesia—Risedronate—osteoporosis	0.000342	0.000803	CcSEcCtD
Gatifloxacin—Pruritus—Estropipate—osteoporosis	0.000341	0.000801	CcSEcCtD
Gatifloxacin—Asthenia—Alendronate—osteoporosis	0.000341	0.0008	CcSEcCtD
Gatifloxacin—Hypersensitivity—Ibandronate—osteoporosis	0.000341	0.0008	CcSEcCtD
Gatifloxacin—Dyspnoea—Risedronate—osteoporosis	0.00034	0.000798	CcSEcCtD
Gatifloxacin—Erythema multiforme—Estradiol—osteoporosis	0.00034	0.000797	CcSEcCtD
Gatifloxacin—Hypotension—Pamidronate—osteoporosis	0.000339	0.000795	CcSEcCtD
Gatifloxacin—Convulsion—Conjugated Estrogens—osteoporosis	0.000339	0.000794	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000337	0.042	CbGpPWpGaD
Gatifloxacin—Pruritus—Alendronate—osteoporosis	0.000336	0.000789	CcSEcCtD
Gatifloxacin—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000336	0.0419	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Risedronate—osteoporosis	0.000336	0.000788	CcSEcCtD
Gatifloxacin—Eye disorder—Estradiol—osteoporosis	0.000336	0.000788	CcSEcCtD
Gatifloxacin—Tinnitus—Estradiol—osteoporosis	0.000335	0.000786	CcSEcCtD
Gatifloxacin—Constipation—Ethinyl Estradiol—osteoporosis	0.000335	0.000785	CcSEcCtD
Gatifloxacin—Confusional state—Zoledronate—osteoporosis	0.000334	0.000783	CcSEcCtD
Gatifloxacin—Hypersensitivity—Calcitriol—osteoporosis	0.000334	0.000783	CcSEcCtD
Gatifloxacin—Chest pain—Conjugated Estrogens—osteoporosis	0.000333	0.00078	CcSEcCtD
Gatifloxacin—Myalgia—Conjugated Estrogens—osteoporosis	0.000333	0.00078	CcSEcCtD
Gatifloxacin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000333	0.00078	CcSEcCtD
Gatifloxacin—Asthenia—Ibandronate—osteoporosis	0.000332	0.000779	CcSEcCtD
Gatifloxacin—Anxiety—Conjugated Estrogens—osteoporosis	0.000332	0.000778	CcSEcCtD
Gatifloxacin—Nausea—Etidronic acid—osteoporosis	0.000331	0.000777	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Zoledronate—osteoporosis	0.000331	0.000777	CcSEcCtD
Gatifloxacin—Oedema—Zoledronate—osteoporosis	0.000331	0.000777	CcSEcCtD
Gatifloxacin—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.00033	0.0412	CbGpPWpGaD
Gatifloxacin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00033	0.000775	CcSEcCtD
Gatifloxacin—Diarrhoea—Estropipate—osteoporosis	0.00033	0.000775	CcSEcCtD
Gatifloxacin—Infection—Zoledronate—osteoporosis	0.000329	0.000772	CcSEcCtD
Gatifloxacin—Insomnia—Pamidronate—osteoporosis	0.000328	0.000769	CcSEcCtD
Gatifloxacin—Pruritus—Ibandronate—osteoporosis	0.000327	0.000768	CcSEcCtD
Gatifloxacin—Constipation—Risedronate—osteoporosis	0.000326	0.000765	CcSEcCtD
Gatifloxacin—Shock—Zoledronate—osteoporosis	0.000326	0.000764	CcSEcCtD
Gatifloxacin—Paraesthesia—Pamidronate—osteoporosis	0.000326	0.000764	CcSEcCtD
Gatifloxacin—Diarrhoea—Alendronate—osteoporosis	0.000325	0.000763	CcSEcCtD
Gatifloxacin—Asthenia—Calcitriol—osteoporosis	0.000325	0.000763	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Zoledronate—osteoporosis	0.000324	0.000761	CcSEcCtD
Gatifloxacin—Dyspnoea—Pamidronate—osteoporosis	0.000323	0.000758	CcSEcCtD
Gatifloxacin—Tachycardia—Zoledronate—osteoporosis	0.000323	0.000758	CcSEcCtD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000323	0.0403	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000322	0.000756	CcSEcCtD
Gatifloxacin—Chills—Estradiol—osteoporosis	0.000322	0.000756	CcSEcCtD
Gatifloxacin—Somnolence—Pamidronate—osteoporosis	0.000322	0.000756	CcSEcCtD
Gatifloxacin—Pruritus—Calcitriol—osteoporosis	0.000321	0.000752	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Zoledronate—osteoporosis	0.00032	0.000751	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00032	0.00075	CcSEcCtD
Gatifloxacin—Diarrhoea—Raloxifene—osteoporosis	0.00032	0.00075	CcSEcCtD
Gatifloxacin—Dyspepsia—Pamidronate—osteoporosis	0.000319	0.000749	CcSEcCtD
Gatifloxacin—Dizziness—Estropipate—osteoporosis	0.000319	0.000749	CcSEcCtD
Gatifloxacin—Oedema—Conjugated Estrogens—osteoporosis	0.000319	0.000748	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000319	0.000748	CcSEcCtD
Gatifloxacin—Infection—Conjugated Estrogens—osteoporosis	0.000317	0.000743	CcSEcCtD
Gatifloxacin—Diarrhoea—Ibandronate—osteoporosis	0.000317	0.000743	CcSEcCtD
Gatifloxacin—Anorexia—Zoledronate—osteoporosis	0.000316	0.000741	CcSEcCtD
Gatifloxacin—Decreased appetite—Pamidronate—osteoporosis	0.000315	0.000739	CcSEcCtD
Gatifloxacin—Dizziness—Alendronate—osteoporosis	0.000314	0.000737	CcSEcCtD
Gatifloxacin—Shock—Conjugated Estrogens—osteoporosis	0.000314	0.000736	CcSEcCtD
Gatifloxacin—Erythema—Estradiol—osteoporosis	0.000313	0.000734	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Risedronate—osteoporosis	0.000312	0.000732	CcSEcCtD
Gatifloxacin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000311	0.00073	CcSEcCtD
Gatifloxacin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000311	0.000729	CcSEcCtD
Gatifloxacin—Constipation—Pamidronate—osteoporosis	0.00031	0.000727	CcSEcCtD
Gatifloxacin—Diarrhoea—Calcitriol—osteoporosis	0.00031	0.000727	CcSEcCtD
Gatifloxacin—Hypotension—Zoledronate—osteoporosis	0.000309	0.000726	CcSEcCtD
Gatifloxacin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000309	0.000725	CcSEcCtD
Gatifloxacin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000309	0.000725	CcSEcCtD
Gatifloxacin—Dizziness—Raloxifene—osteoporosis	0.000309	0.000725	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000308	0.000723	CcSEcCtD
Gatifloxacin—Flatulence—Estradiol—osteoporosis	0.000308	0.000723	CcSEcCtD
Gatifloxacin—Tension—Estradiol—osteoporosis	0.000307	0.00072	CcSEcCtD
Gatifloxacin—Vomiting—Estropipate—osteoporosis	0.000307	0.00072	CcSEcCtD
Gatifloxacin—Dysgeusia—Estradiol—osteoporosis	0.000306	0.000718	CcSEcCtD
Gatifloxacin—Dizziness—Ibandronate—osteoporosis	0.000306	0.000718	CcSEcCtD
Gatifloxacin—Rash—Estropipate—osteoporosis	0.000304	0.000714	CcSEcCtD
Gatifloxacin—Dermatitis—Estropipate—osteoporosis	0.000304	0.000713	CcSEcCtD
Gatifloxacin—Anorexia—Conjugated Estrogens—osteoporosis	0.000304	0.000713	CcSEcCtD
Gatifloxacin—Nervousness—Estradiol—osteoporosis	0.000304	0.000713	CcSEcCtD
Gatifloxacin—Urticaria—Risedronate—osteoporosis	0.000303	0.000711	CcSEcCtD
Gatifloxacin—Back pain—Estradiol—osteoporosis	0.000302	0.00071	CcSEcCtD
Gatifloxacin—Headache—Estropipate—osteoporosis	0.000302	0.000709	CcSEcCtD
Gatifloxacin—Vomiting—Alendronate—osteoporosis	0.000302	0.000709	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000302	0.000708	CcSEcCtD
Gatifloxacin—Abdominal pain—Risedronate—osteoporosis	0.000302	0.000707	CcSEcCtD
Gatifloxacin—Body temperature increased—Risedronate—osteoporosis	0.000302	0.000707	CcSEcCtD
Gatifloxacin—Muscle spasms—Estradiol—osteoporosis	0.000301	0.000705	CcSEcCtD
Gatifloxacin—Rash—Alendronate—osteoporosis	0.0003	0.000703	CcSEcCtD
Gatifloxacin—Insomnia—Zoledronate—osteoporosis	0.0003	0.000703	CcSEcCtD
Gatifloxacin—Dermatitis—Alendronate—osteoporosis	0.000299	0.000702	CcSEcCtD
Gatifloxacin—Feeling abnormal—Pamidronate—osteoporosis	0.000299	0.000701	CcSEcCtD
Gatifloxacin—Hypotension—Conjugated Estrogens—osteoporosis	0.000298	0.000699	CcSEcCtD
Gatifloxacin—Headache—Alendronate—osteoporosis	0.000298	0.000699	CcSEcCtD
Gatifloxacin—Paraesthesia—Zoledronate—osteoporosis	0.000297	0.000698	CcSEcCtD
Gatifloxacin—Vomiting—Raloxifene—osteoporosis	0.000297	0.000697	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000296	0.000696	CcSEcCtD
Gatifloxacin—Dyspnoea—Zoledronate—osteoporosis	0.000295	0.000693	CcSEcCtD
Gatifloxacin—Rash—Raloxifene—osteoporosis	0.000295	0.000692	CcSEcCtD
Gatifloxacin—Dermatitis—Raloxifene—osteoporosis	0.000294	0.000691	CcSEcCtD
Gatifloxacin—Somnolence—Zoledronate—osteoporosis	0.000294	0.000691	CcSEcCtD
Gatifloxacin—Vomiting—Ibandronate—osteoporosis	0.000294	0.00069	CcSEcCtD
Gatifloxacin—Tremor—Estradiol—osteoporosis	0.000293	0.000687	CcSEcCtD
Gatifloxacin—Headache—Raloxifene—osteoporosis	0.000293	0.000687	CcSEcCtD
Gatifloxacin—Rash—Ibandronate—osteoporosis	0.000292	0.000685	CcSEcCtD
Gatifloxacin—Dermatitis—Ibandronate—osteoporosis	0.000292	0.000684	CcSEcCtD
Gatifloxacin—Dyspepsia—Zoledronate—osteoporosis	0.000292	0.000684	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000291	0.000682	CcSEcCtD
Gatifloxacin—Headache—Ibandronate—osteoporosis	0.00029	0.00068	CcSEcCtD
Gatifloxacin—Insomnia—Conjugated Estrogens—osteoporosis	0.000288	0.000677	CcSEcCtD
Gatifloxacin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000288	0.000676	CcSEcCtD
Gatifloxacin—Vomiting—Calcitriol—osteoporosis	0.000288	0.000676	CcSEcCtD
Gatifloxacin—Decreased appetite—Zoledronate—osteoporosis	0.000288	0.000675	CcSEcCtD
Gatifloxacin—Agitation—Estradiol—osteoporosis	0.000287	0.000674	CcSEcCtD
Gatifloxacin—Nausea—Estropipate—osteoporosis	0.000287	0.000673	CcSEcCtD
Gatifloxacin—Body temperature increased—Pamidronate—osteoporosis	0.000287	0.000672	CcSEcCtD
Gatifloxacin—Abdominal pain—Pamidronate—osteoporosis	0.000287	0.000672	CcSEcCtD
Gatifloxacin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000286	0.000672	CcSEcCtD
Gatifloxacin—Angioedema—Estradiol—osteoporosis	0.000286	0.00067	CcSEcCtD
Gatifloxacin—Rash—Calcitriol—osteoporosis	0.000286	0.00067	CcSEcCtD
Gatifloxacin—Dermatitis—Calcitriol—osteoporosis	0.000285	0.00067	CcSEcCtD
Gatifloxacin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000284	0.000667	CcSEcCtD
Gatifloxacin—Headache—Calcitriol—osteoporosis	0.000284	0.000666	CcSEcCtD
Gatifloxacin—Somnolence—Conjugated Estrogens—osteoporosis	0.000284	0.000665	CcSEcCtD
Gatifloxacin—Constipation—Zoledronate—osteoporosis	0.000283	0.000664	CcSEcCtD
Gatifloxacin—Nausea—Alendronate—osteoporosis	0.000282	0.000662	CcSEcCtD
Gatifloxacin—Hypersensitivity—Risedronate—osteoporosis	0.000281	0.000659	CcSEcCtD
Gatifloxacin—Vertigo—Estradiol—osteoporosis	0.000281	0.000659	CcSEcCtD
Gatifloxacin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000281	0.000659	CcSEcCtD
Gatifloxacin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000281	0.000658	CcSEcCtD
Gatifloxacin—Syncope—Estradiol—osteoporosis	0.00028	0.000658	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—CAP1—osteoporosis	0.000279	0.0348	CbGpPWpGaD
Gatifloxacin—Nausea—Raloxifene—osteoporosis	0.000278	0.000651	CcSEcCtD
Gatifloxacin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000277	0.00065	CcSEcCtD
Gatifloxacin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000277	0.000649	CcSEcCtD
Gatifloxacin—Palpitations—Estradiol—osteoporosis	0.000276	0.000648	CcSEcCtD
Gatifloxacin—Nausea—Ibandronate—osteoporosis	0.000275	0.000645	CcSEcCtD
Gatifloxacin—Loss of consciousness—Estradiol—osteoporosis	0.000275	0.000645	CcSEcCtD
Gatifloxacin—Asthenia—Risedronate—osteoporosis	0.000274	0.000642	CcSEcCtD
Gatifloxacin—Feeling abnormal—Zoledronate—osteoporosis	0.000273	0.00064	CcSEcCtD
Gatifloxacin—Constipation—Conjugated Estrogens—osteoporosis	0.000273	0.00064	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000271	0.0338	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000271	0.000635	CcSEcCtD
Gatifloxacin—Hypertension—Estradiol—osteoporosis	0.00027	0.000633	CcSEcCtD
Gatifloxacin—Pruritus—Risedronate—osteoporosis	0.00027	0.000633	CcSEcCtD
Gatifloxacin—Nausea—Calcitriol—osteoporosis	0.000269	0.000631	CcSEcCtD
Gatifloxacin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000268	0.000628	CcSEcCtD
Gatifloxacin—Hypersensitivity—Pamidronate—osteoporosis	0.000267	0.000627	CcSEcCtD
Gatifloxacin—Arthralgia—Estradiol—osteoporosis	0.000266	0.000625	CcSEcCtD
Gatifloxacin—Myalgia—Estradiol—osteoporosis	0.000266	0.000625	CcSEcCtD
Gatifloxacin—Chest pain—Estradiol—osteoporosis	0.000266	0.000625	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000266	0.0332	CbGpPWpGaD
Gatifloxacin—Anxiety—Estradiol—osteoporosis	0.000265	0.000622	CcSEcCtD
Gatifloxacin—Urticaria—Zoledronate—osteoporosis	0.000263	0.000617	CcSEcCtD
Gatifloxacin—Body temperature increased—Zoledronate—osteoporosis	0.000262	0.000614	CcSEcCtD
Gatifloxacin—Abdominal pain—Zoledronate—osteoporosis	0.000262	0.000614	CcSEcCtD
Gatifloxacin—Diarrhoea—Risedronate—osteoporosis	0.000261	0.000612	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000261	0.000612	CcSEcCtD
Gatifloxacin—Asthenia—Pamidronate—osteoporosis	0.00026	0.00061	CcSEcCtD
Gatifloxacin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000259	0.000607	CcSEcCtD
Gatifloxacin—Confusional state—Estradiol—osteoporosis	0.000257	0.000604	CcSEcCtD
Gatifloxacin—Pruritus—Pamidronate—osteoporosis	0.000257	0.000602	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Estradiol—osteoporosis	0.000255	0.000599	CcSEcCtD
Gatifloxacin—Oedema—Estradiol—osteoporosis	0.000255	0.000599	CcSEcCtD
Gatifloxacin—Infection—Estradiol—osteoporosis	0.000254	0.000595	CcSEcCtD
Gatifloxacin—Urticaria—Conjugated Estrogens—osteoporosis	0.000253	0.000594	CcSEcCtD
Gatifloxacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000253	0.0315	CbGpPWpGaD
Gatifloxacin—Dizziness—Risedronate—osteoporosis	0.000252	0.000592	CcSEcCtD
Gatifloxacin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000252	0.000591	CcSEcCtD
Gatifloxacin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000252	0.000591	CcSEcCtD
Gatifloxacin—Shock—Estradiol—osteoporosis	0.000251	0.000589	CcSEcCtD
Gatifloxacin—Tachycardia—Estradiol—osteoporosis	0.000249	0.000584	CcSEcCtD
Gatifloxacin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000249	0.000584	CcSEcCtD
Gatifloxacin—Diarrhoea—Pamidronate—osteoporosis	0.000248	0.000582	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Estradiol—osteoporosis	0.000247	0.000579	CcSEcCtD
Gatifloxacin—Rash—Ethinyl Estradiol—osteoporosis	0.000247	0.000579	CcSEcCtD
Gatifloxacin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000246	0.000578	CcSEcCtD
Gatifloxacin—Headache—Ethinyl Estradiol—osteoporosis	0.000245	0.000575	CcSEcCtD
Gatifloxacin—Hypersensitivity—Zoledronate—osteoporosis	0.000244	0.000572	CcSEcCtD
Gatifloxacin—Vomiting—Risedronate—osteoporosis	0.000243	0.000569	CcSEcCtD
Gatifloxacin—Rash—Risedronate—osteoporosis	0.00024	0.000564	CcSEcCtD
Gatifloxacin—Dermatitis—Risedronate—osteoporosis	0.00024	0.000564	CcSEcCtD
Gatifloxacin—Dizziness—Pamidronate—osteoporosis	0.00024	0.000562	CcSEcCtD
Gatifloxacin—Headache—Risedronate—osteoporosis	0.000239	0.000561	CcSEcCtD
Gatifloxacin—Asthenia—Zoledronate—osteoporosis	0.000238	0.000557	CcSEcCtD
Gatifloxacin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000235	0.000551	CcSEcCtD
Gatifloxacin—Pruritus—Zoledronate—osteoporosis	0.000234	0.00055	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000233	0.000546	CcSEcCtD
Gatifloxacin—Nausea—Ethinyl Estradiol—osteoporosis	0.000232	0.000545	CcSEcCtD
Gatifloxacin—Insomnia—Estradiol—osteoporosis	0.000231	0.000542	CcSEcCtD
Gatifloxacin—Vomiting—Pamidronate—osteoporosis	0.000231	0.000541	CcSEcCtD
Gatifloxacin—Paraesthesia—Estradiol—osteoporosis	0.000229	0.000538	CcSEcCtD
Gatifloxacin—Asthenia—Conjugated Estrogens—osteoporosis	0.000229	0.000537	CcSEcCtD
Gatifloxacin—Rash—Pamidronate—osteoporosis	0.000229	0.000536	CcSEcCtD
Gatifloxacin—Dermatitis—Pamidronate—osteoporosis	0.000228	0.000536	CcSEcCtD
Gatifloxacin—Dyspnoea—Estradiol—osteoporosis	0.000228	0.000534	CcSEcCtD
Gatifloxacin—Headache—Pamidronate—osteoporosis	0.000227	0.000533	CcSEcCtD
Gatifloxacin—Somnolence—Estradiol—osteoporosis	0.000227	0.000532	CcSEcCtD
Gatifloxacin—Diarrhoea—Zoledronate—osteoporosis	0.000227	0.000532	CcSEcCtD
Gatifloxacin—Nausea—Risedronate—osteoporosis	0.000227	0.000531	CcSEcCtD
Gatifloxacin—Pruritus—Conjugated Estrogens—osteoporosis	0.000226	0.000529	CcSEcCtD
Gatifloxacin—Dyspepsia—Estradiol—osteoporosis	0.000225	0.000527	CcSEcCtD
Gatifloxacin—Decreased appetite—Estradiol—osteoporosis	0.000222	0.00052	CcSEcCtD
Gatifloxacin—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.00022	0.0274	CbGpPWpGaD
Gatifloxacin—Dizziness—Zoledronate—osteoporosis	0.000219	0.000514	CcSEcCtD
Gatifloxacin—Constipation—Estradiol—osteoporosis	0.000218	0.000512	CcSEcCtD
Gatifloxacin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000218	0.000512	CcSEcCtD
Gatifloxacin—Nausea—Pamidronate—osteoporosis	0.000215	0.000505	CcSEcCtD
Gatifloxacin—Dizziness—Conjugated Estrogens—osteoporosis	0.000211	0.000495	CcSEcCtD
Gatifloxacin—Vomiting—Zoledronate—osteoporosis	0.000211	0.000494	CcSEcCtD
Gatifloxacin—Feeling abnormal—Estradiol—osteoporosis	0.00021	0.000493	CcSEcCtD
Gatifloxacin—Rash—Zoledronate—osteoporosis	0.000209	0.00049	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Estradiol—osteoporosis	0.000209	0.00049	CcSEcCtD
Gatifloxacin—Dermatitis—Zoledronate—osteoporosis	0.000209	0.000489	CcSEcCtD
Gatifloxacin—Headache—Zoledronate—osteoporosis	0.000207	0.000487	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—PLEK—osteoporosis	0.000203	0.0253	CbGpPWpGaD
Gatifloxacin—Vomiting—Conjugated Estrogens—osteoporosis	0.000203	0.000476	CcSEcCtD
Gatifloxacin—Urticaria—Estradiol—osteoporosis	0.000203	0.000476	CcSEcCtD
Gatifloxacin—Abdominal pain—Estradiol—osteoporosis	0.000202	0.000473	CcSEcCtD
Gatifloxacin—Body temperature increased—Estradiol—osteoporosis	0.000202	0.000473	CcSEcCtD
Gatifloxacin—Rash—Conjugated Estrogens—osteoporosis	0.000201	0.000472	CcSEcCtD
Gatifloxacin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000201	0.000471	CcSEcCtD
Gatifloxacin—Headache—Conjugated Estrogens—osteoporosis	0.0002	0.000469	CcSEcCtD
Gatifloxacin—Nausea—Zoledronate—osteoporosis	0.000197	0.000462	CcSEcCtD
Gatifloxacin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000194	0.0242	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000193	0.0241	CbGpPWpGaD
Gatifloxacin—Nausea—Conjugated Estrogens—osteoporosis	0.000189	0.000444	CcSEcCtD
Gatifloxacin—Hypersensitivity—Estradiol—osteoporosis	0.000188	0.000441	CcSEcCtD
Gatifloxacin—Asthenia—Estradiol—osteoporosis	0.000183	0.00043	CcSEcCtD
Gatifloxacin—Pruritus—Estradiol—osteoporosis	0.000181	0.000424	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—TLN1—osteoporosis	0.000175	0.0218	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Estradiol—osteoporosis	0.000175	0.00041	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—VCL—osteoporosis	0.000173	0.0215	CbGpPWpGaD
Gatifloxacin—Dizziness—Estradiol—osteoporosis	0.000169	0.000396	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000167	0.0208	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000164	0.0205	CbGpPWpGaD
Gatifloxacin—Vomiting—Estradiol—osteoporosis	0.000162	0.000381	CcSEcCtD
Gatifloxacin—Rash—Estradiol—osteoporosis	0.000161	0.000378	CcSEcCtD
Gatifloxacin—Dermatitis—Estradiol—osteoporosis	0.000161	0.000377	CcSEcCtD
Gatifloxacin—Headache—Estradiol—osteoporosis	0.00016	0.000375	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000157	0.0195	CbGpPWpGaD
Gatifloxacin—Nausea—Estradiol—osteoporosis	0.000152	0.000356	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—FGA—osteoporosis	0.000131	0.0163	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000125	0.0155	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000124	0.0155	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—FGB—osteoporosis	0.000119	0.0148	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000114	0.0142	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000113	0.0141	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.0001	0.0125	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	9.84e-05	0.0123	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SOD2—osteoporosis	9.27e-05	0.0116	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	9e-05	0.0112	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—GPX1—osteoporosis	8.85e-05	0.011	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—MTHFR—osteoporosis	8.17e-05	0.0102	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—WDR1—osteoporosis	8.08e-05	0.0101	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	7.76e-05	0.00968	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	7.65e-05	0.00955	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	7.37e-05	0.00919	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	7.03e-05	0.00877	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	6.49e-05	0.00809	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.43e-05	0.00802	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	6.39e-05	0.00798	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CAP1—osteoporosis	6.38e-05	0.00796	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.09e-05	0.0076	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5.96e-05	0.00743	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	5.8e-05	0.00723	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—IGF1—osteoporosis	5.39e-05	0.00672	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	5.28e-05	0.00658	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	5.13e-05	0.0064	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MGLL—osteoporosis	5.07e-05	0.00633	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL1B—osteoporosis	4.85e-05	0.00605	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.74e-05	0.00591	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLEK—osteoporosis	4.64e-05	0.00579	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ANXA2—osteoporosis	4.64e-05	0.00579	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.62e-05	0.00576	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	4.32e-05	0.00539	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.02e-05	0.00501	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TLN1—osteoporosis	4e-05	0.00499	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VCL—osteoporosis	3.94e-05	0.00492	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.85e-05	0.0048	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.69e-05	0.0046	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—osteoporosis	3.52e-05	0.00439	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.49e-05	0.00435	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAP1A—osteoporosis	3.3e-05	0.00411	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—osteoporosis	3.23e-05	0.00403	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.14e-05	0.00392	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.08e-05	0.00384	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FGA—osteoporosis	2.99e-05	0.00373	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FDPS—osteoporosis	2.86e-05	0.00357	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PKM—osteoporosis	2.86e-05	0.00357	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—osteoporosis	2.84e-05	0.00354	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.79e-05	0.00348	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FGB—osteoporosis	2.72e-05	0.00339	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPD2—osteoporosis	2.71e-05	0.00338	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PGLS—osteoporosis	2.71e-05	0.00338	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ATIC—osteoporosis	2.48e-05	0.0031	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PNP—osteoporosis	2.48e-05	0.0031	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.39e-05	0.00298	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.25e-05	0.00281	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—OXCT1—osteoporosis	2.11e-05	0.00263	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CA2—osteoporosis	2.11e-05	0.00263	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MGLL—osteoporosis	2.06e-05	0.00257	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.94e-05	0.00242	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—IDH2—osteoporosis	1.75e-05	0.00218	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP27A1—osteoporosis	1.64e-05	0.00205	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACP5—osteoporosis	1.6e-05	0.002	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.58e-05	0.00197	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.51e-05	0.00188	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TPI1—osteoporosis	1.49e-05	0.00185	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.43e-05	0.00179	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—P4HB—osteoporosis	1.4e-05	0.00174	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GAPDH—osteoporosis	1.37e-05	0.00171	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—RAP1A—osteoporosis	1.34e-05	0.00167	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—osteoporosis	1.23e-05	0.00154	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.17e-05	0.00145	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ENO1—osteoporosis	1.08e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSMA2—osteoporosis	1.06e-05	0.00133	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSMA5—osteoporosis	1.06e-05	0.00133	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP19A1—osteoporosis	8.64e-06	0.00108	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—osteoporosis	7.38e-06	0.000921	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADCY5—osteoporosis	7.06e-06	0.00088	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX1—osteoporosis	7.03e-06	0.000877	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—osteoporosis	6.49e-06	0.00081	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—POMC—osteoporosis	5.19e-06	0.000647	CbGpPWpGaD
